Acceptance of COVID-19 vaccine among persons experiencing homelessness in the City of Rome, Italy

Eur Rev Med Pharmacol Sci. 2021 Apr;25(7):3132-3135. doi: 10.26355/eurrev_202104_25568.

Abstract

Objective: Vulnerable populations are being more severely impacted by the ongoing pandemic, and the recent release of vaccines for Coronavirus Disease 19 (COVID-19) may offer them protection. The aim of this study was to investigate the willingness of homeless persons to be vaccinated against COVID-19; secondary aims were to analyze the immunization coverage for other conditions.

Patients and methods: The acceptance of COVID-19 vaccine and immunization coverage for other conditions were investigated through a form in 112 persons experiencing homelessness referring to the primary care medical services of the Eleemosynaria Apostolica, Holy See.

Results: Most subjects, with a male preponderance, were willing to be vaccinated against COVID-19 (64.3%), 3.6% were unsure and 32.1% preferred not to be vaccinated. When answering questions on the immunization coverage for tuberculosis and hepatitis A and B, most subjects reported not to be vaccinated (48.2%, 56.2% and 55.3%, respectively) or did not know (33%, 28.6% and 27.7%).

Conclusions: A significant portion of our sample declared to be willing to be vaccinated against COVID-19. It would be auspicious that the recent statements from several countries on the importance to extend COVID-19 vaccination to fragile populations be followed by the distribution of the vaccine to these populations.

MeSH terms

  • Adult
  • Aged
  • Attitude to Health*
  • COVID-19 / prevention & control*
  • COVID-19 Vaccines / therapeutic use*
  • Female
  • Hepatitis A / prevention & control
  • Hepatitis A Vaccines / therapeutic use
  • Hepatitis B / prevention & control
  • Hepatitis B Vaccines / therapeutic use
  • Humans
  • Ill-Housed Persons*
  • Influenza Vaccines / therapeutic use
  • Influenza, Human / prevention & control
  • Male
  • Middle Aged
  • Patient Acceptance of Health Care
  • Rome
  • SARS-CoV-2
  • Tuberculosis / prevention & control
  • Tuberculosis Vaccines / therapeutic use
  • Vaccination Coverage / statistics & numerical data*
  • Young Adult

Substances

  • COVID-19 Vaccines
  • Hepatitis A Vaccines
  • Hepatitis B Vaccines
  • Influenza Vaccines
  • Tuberculosis Vaccines